Tag: global synthetic hormones market

Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.

Synthetic Hormones Market Forecast: What Value Will The Market Reach By 2030?

The synthetic hormones market has observed consistent growth in its size over recent years. It is projected to expand from $6.71 billion in 2025 to $7 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 4.4%. The historical expansion of this market can be attributed to advancements in chemical synthesis, an increasing prevalence of hormonal disorders, greater awareness of hormone replacement therapy, the broadening of hospital and retail pharmacy networks, and the early adoption of insulin and growth hormones.

The synthetic hormones market is projected to experience consistent expansion over the upcoming years. This market is anticipated to reach a valuation of $8.34 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 4.5%. Factors contributing to this growth during the forecast period include the incorporation of AI into hormone therapy, the emergence of oral and non-invasive methods for hormone delivery, the increasing prevalence of personalized medicine, the broadening reach of online pharmacy platforms, and advancements in peptide and amino acid derivative hormones. Key trends anticipated during the same period encompass the evolution of personalized hormone therapy, sophisticated drug delivery mechanisms, novel synthetic hormone formulations, increased acceptance of hormone replacement therapy, and adherence to regulatory compliance and quality standards.

Get A Free Sample Report With In-Depth Market Insights:

https://thebusinessresearchcompany.com/sample_request?id=70827845&type=smp&name=Synthetic%20Hormones%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Synthetic Hormones Market Growth Factors Behind Sustained Expansion

The synthetic hormones market is anticipated to expand due to the increasing incidence of hormonal imbalances. Such imbalances occur when the body generates either an excessive or insufficient quantity of specific hormones, leading to disturbances often stemming from aging, stress, lifestyle elements, or underlying health issues. These conditions frequently necessitate therapeutic intervention, with synthetic hormones playing a crucial role by supplementing or substituting deficient hormones to restore regular physiological function and alleviate accompanying symptoms. The rising demand for hormone replacement therapy (HRT) reflects the growing prevalence of these conditions. For example, in January 2025, data from the World Health Organization, an intergovernmental organization located in Switzerland, indicated that polycystic ovary syndrome is a significant public health issue and one of the most common hormonal disorders affecting women of reproductive age, impacting an estimated 6–13%, with up to 70% of cases remaining undiagnosed. Therefore, the escalating occurrence of hormonal imbalances is a primary catalyst for the growth of the synthetic hormones market.

Synthetic Hormones Market Segment Trends And Revenue Contributors

The synthetic hormones market covered in this report is segmented –

1) By Product Type: Steroid Hormones, Peptide Hormone, Amino Acid Derivatives, Other Product Types

2) By Route of Administration: Oral, Nasal, Topical, Intravenous

3) By Application: Growth Hormone Deficiency, Thyroid Hormone Deficiency, Menopause, Male Hypogonadism, Other Applications

4) By End User: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Steroid Hormones: Corticosteroids, Estrogens and Progesterone, Androgens, Progestins

2) By Peptide Hormones: Insulin, Growth Hormones, Thyroid Stimulating Hormones, Leptin

3) By Amino Acid Derivatives: Thyroxine (T4), Epinephrine (Adrenaline), Melatonin

4) By Other Product Types: Vitamin D Derivatives, Prostaglandins, Gonadotropins

Synthetic Hormones Market Industry Trends Fueling Future Revenue Growth

Major companies in the synthetic hormone market are concentrating on developing innovative biosimilar formulations, such as high-concentration recombinant human growth hormone (rhGH), to meet the increasing demand for more accessible and affordable therapies for growth-hormone deficiency and short stature. High-concentration rhGH refers to a type of synthetic growth hormone, typically somatropin, created using recombinant DNA technology, which features an increased drug load per volume. This design allows for smaller injection volumes, greater user convenience, and potentially improved treatment adherence compared to conventional lower-concentration formulations. For example, in May 2025, Sandoz AG, a Switzerland-based leader in generics and biosimilars, launched OMNITROPE with a new 15 mg / 1.5 mL concentration for the Egyptian market. This formulation contains somatropin produced via recombinant DNA technology in bacteria, is functionally identical to human endogenous growth hormone, and is provided in a more concentrated form to reduce the injection burden and minimize treatment interruptions. It is indicated for pediatric short stature (e.g., in Turner syndrome, small-for-gestational-age children, Prader–Willi syndrome) and adult GH deficiency, and its pricing is structured to broaden access under Egypt’s Vision 2030 public-health initiative.

Synthetic Hormones Market Competitive Landscape: Which Companies Lead The Industry?

Major companies operating in the synthetic hormones market are Pfizer Inc., Johnson & Johnson, AbbVie Inc., Bristol Myers Squibb Company, Sanofi SA, AstraZeneca PLC, Novartis AG, GlaxoSmithKline PLC, Boehringer Ingelheim International GmbH, Novo Nordisk A/S, Merck & Co. Inc, Teva Pharmaceutical Industries Ltd., Ferring B.V., Endo Pharmaceuticals Inc., Lupin Pharmaceuticals Inc., IBSA Institute Biochimique SA, American Regent Inc., McGuff Pharmaceuticals Inc., Anhui Anke Biotechnology Co.Ltd, Acerus Pharmaceuticals Corporation, Slayback Pharma LLC

View The Full Synthetic Hormones Market Report:

https://thebusinessresearchcompany.com/report/synthetic-hormones-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Synthetic Hormones Market Largest Region: Which Geography Holds The Biggest Share?

North America was the largest region in the synthetic hormones market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the synthetic hormones market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.

Synthetic Hormones Market Size And Revenue Forecast Through 2030

The market for synthetic hormones has experienced consistent expansion in recent times. Valued at $6.71 billion in 2025, it is projected to reach $7 billion by 2026, reflecting a compound annual growth rate (CAGR) of 4.4%. This historical growth has been driven by progress in chemical synthesis methods, a growing incidence of hormonal conditions, heightened awareness about hormone replacement therapy, the broadening of hospital and retail pharmacy infrastructures, and the early uptake of insulin and growth hormones.

The synthetic hormones market is anticipated to experience consistent expansion over the coming years, with projections indicating it will reach a value of $8.34 billion by 2030, driven by a compound annual growth rate (CAGR) of 4.5%. This forecasted growth is primarily fueled by the incorporation of artificial intelligence into hormone therapies, the emergence of oral and non-invasive hormone delivery methods, an increasing emphasis on personalized medicine, the rise of digital pharmacy platforms, and advancements in peptide and amino acid derivative hormones. Key trends shaping the future include the advancement of tailored hormone therapies, the evolution of sophisticated drug delivery mechanisms, breakthroughs in synthetic hormone formulations, a rising uptake of hormone replacement treatments, and a sustained focus on ensuring compliance with regulatory standards and maintaining high-quality benchmarks.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=14515&type=smp&utm_source=BlogsPR&utm_medium=Paid&utm_campaign=Jul_PR

Synthetic Hormones Market Industry Drivers: What Is Driving Revenue Growth?

The anticipated expansion of the synthetic hormones market is being driven by an increasing frequency of hormonal imbalances. Such imbalances arise when the body produces an excess or deficiency of specific hormones, often triggered by aging, stress, lifestyle choices, or underlying health issues. These disruptions commonly call for medical treatment, where synthetic hormones help restore normal bodily functions and ease related symptoms by supplementing or substituting deficient hormones. This trend is supported by rising demand for hormone replacement therapy (HRT), which mirrors the growing prevalence of these disorders. For example, in January 2025, the World Health Organization, an intergovernmental body based in Switzerland, reported that polycystic ovary syndrome represents a significant global health challenge and ranks among the most common hormonal issues for women of reproductive age, impacting an estimated 6–13%, with up to 70% of cases remaining undetected. Consequently, the climb in hormonal imbalance cases is fueling growth in the synthetic hormones market.

Synthetic Hormones Market Segmentation: How Is The Market Structured Across Key Categories?

The synthetic hormones market covered in this report is segmented –

1) By Product Type: Steroid Hormones, Peptide Hormone, Amino Acid Derivatives, Other Product Types

2) By Route of Administration: Oral, Nasal, Topical, Intravenous

3) By Application: Growth Hormone Deficiency, Thyroid Hormone Deficiency, Menopause, Male Hypogonadism, Other Applications

4) By End User: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Steroid Hormones: Corticosteroids, Estrogens and Progesterone, Androgens, Progestins

2) By Peptide Hormones: Insulin, Growth Hormones, Thyroid Stimulating Hormones, Leptin

3) By Amino Acid Derivatives: Thyroxine (T4), Epinephrine (Adrenaline), Melatonin

4) By Other Product Types: Vitamin D Derivatives, Prostaglandins, Gonadotropins

Synthetic Hormones Market Growth Trends: What Is Influencing The Future Outlook?

Key players in the synthetic hormone industry are increasingly concentrating on the advancement of groundbreaking biosimilar options, specifically high-concentration recombinant human growth hormone (rhGH), in response to the growing need for more affordable and easily accessible treatments for growth-hormone deficiencies and short stature. This high-concentration rhGH represents a manufactured version of growth hormone (commonly somatropin), engineered through recombinant DNA methods, which features a higher medication dosage per milliliter. As a result, it enables smaller injection amounts, improved ease of use, and often enhanced patient adherence compared to earlier, lower-concentration alternatives. A notable example occurred in May 2025, when Sandoz AG, a prominent generics and biosimilars firm headquartered in Switzerland, introduced OMNITROPE in Egypt at a 15 mg / 1.5 mL concentration. This product utilizes somatropin produced via recombinant DNA technology in bacterial cultures, is biologically equivalent to naturally occurring human growth hormone, and is supplied in a more potent formulation aimed at lessening the injection frequency and preventing treatment gaps. Its indications cover pediatric conditions involving short stature, such as Turner syndrome, children born small for gestational age, and Prader–Willi syndrome, as well as adult growth-hormone deficiency. Additionally, it is priced to improve accessibility as part of Egypt’s Vision 2030 public-health initiative.

Synthetic Hormones Market Competitive Landscape And Leading Companies

Major companies operating in the synthetic hormones market are Pfizer Inc., Johnson & Johnson, AbbVie Inc., Bristol Myers Squibb Company, Sanofi SA, AstraZeneca PLC, Novartis AG, GlaxoSmithKline PLC, Boehringer Ingelheim International GmbH, Novo Nordisk A/S, Merck & Co. Inc, Teva Pharmaceutical Industries Ltd., Ferring B.V., Endo Pharmaceuticals Inc., Lupin Pharmaceuticals Inc., IBSA Institute Biochimique SA, American Regent Inc., McGuff Pharmaceuticals Inc., Anhui Anke Biotechnology Co.Ltd, Acerus Pharmaceuticals Corporation, Slayback Pharma LLC

Access The Complete Synthetic Hormones Market Report:

https://www.thebusinessresearchcompany.com/report/synthetic-hormones-global-market-report?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=Jul_PR

Synthetic Hormones Market Largest Region By Revenue And Market Share

North America was the largest region in the synthetic hormones market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the synthetic hormones market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

By 2030, How Much Growth In Market Size Is Expected For The Synthetic Hormones Market?

The synthetic hormones market has experienced consistent growth in recent years. It is projected to expand from $6.71 billion in 2025 to $7 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 4.4%. The expansion observed in prior periods can be attributed to various factors such as advancements in chemical synthesis, a rising incidence of hormonal disorders, increased awareness regarding hormone replacement therapy, the broadening reach of hospital and retail pharmacy networks, and the early adoption of insulin and growth hormones.

The synthetic hormones market is anticipated to experience consistent expansion over the coming years. By 2030, its value is projected to reach $8.34 billion, exhibiting a compound annual growth rate (CAGR) of 4.5%. This growth during the forecast period is propelled by factors such as the incorporation of AI in hormone therapy, advancements in oral and non-invasive hormone delivery methods, the rise of personalized medicine, the proliferation of online pharmacy platforms, and breakthroughs in peptide and amino acid derivative hormones. Key developments expected in this period encompass the evolution of personalized hormone therapy, sophisticated drug delivery systems, novel synthetic hormone formulations, increased adoption of hormone replacement therapy, and adherence to regulatory compliance and quality standards.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=14515&type=smp

What Core Drivers Are Transforming The Synthetic Hormones Market?

An increasing occurrence of hormonal imbalances is anticipated to drive the expansion of the synthetic hormones market in the future. These imbalances manifest when the body produces an inadequate or excessive amount of specific hormones, leading to disruptions stemming from factors like aging, stress, lifestyle choices, or underlying health conditions. Therapeutic intervention is often required for these conditions, with synthetic hormones serving a critical function by either supplementing or replacing deficient hormones to reinstate normal physiological processes and alleviate related symptoms. The growing need for hormone replacement therapy (HRT) underscores the increasing prevalence of these issues. For example, in January 2025, the World Health Organization, an intergovernmental organization based in Switzerland, highlighted polycystic ovary syndrome as a major public health concern and one of the most widespread hormonal disorders among women of reproductive age, affecting an estimated 6–13%, with up to 70% of cases remaining undiagnosed. Thus, the escalating incidence of hormonal imbalances is propelling the growth of the synthetic hormones market.

How Does Segment Analysis Break Down The Synthetic Hormones Market Structure?

The synthetic hormones market covered in this report is segmented –

1) By Product Type: Steroid Hormones, Peptide Hormone, Amino Acid Derivatives, Other Product Types

2) By Route of Administration: Oral, Nasal, Topical, Intravenous

3) By Application: Growth Hormone Deficiency, Thyroid Hormone Deficiency, Menopause, Male Hypogonadism, Other Applications

4) By End User: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Steroid Hormones: Corticosteroids, Estrogens and Progesterone, Androgens, Progestins

2) By Peptide Hormones: Insulin, Growth Hormones, Thyroid Stimulating Hormones, Leptin

3) By Amino Acid Derivatives: Thyroxine (T4), Epinephrine (Adrenaline), Melatonin

4) By Other Product Types: Vitamin D Derivatives, Prostaglandins, Gonadotropins

What Trends Are Influencing The Future Of The Synthetic Hormones Market?

Major companies operating within the synthetic hormone market are strategically focusing on creating advanced biosimilar formulations, notably high-concentration recombinant human growth hormone (rhGH), to meet the growing demand for more accessible and affordable therapeutic options for growth-hormone deficiency and short stature. High-concentration rhGH describes a form of synthetic growth hormone, typically somatropin, generated using recombinant DNA technology, which boasts an increased drug content per volume. This innovation leads to smaller injection volumes, enhanced convenience, and potentially greater adherence to treatment compared to conventional lower-concentration versions. For example, in May 2025, Sandoz AG, a Switzerland-based leader in generics and biosimilars, launched OMNITROPE in a novel 15 mg / 1.5 mL concentration tailored for the Egyptian market. This particular formulation features somatropin produced via recombinant DNA technology in bacteria, which is functionally identical to human endogenous growth hormone. It is presented in a more concentrated format to alleviate injection burden and minimize treatment interruptions. OMNITROPE is indicated for pediatric short stature (e.g., in Turner syndrome, small-for-gestational-age children, Prader–Willi syndrome) and adult GH deficiency, and its pricing is structured to broaden access under Egypt’s Vision 2030 public-health initiative.

Which Organizations Are Operating Within The Synthetic Hormones Market?

Major companies operating in the synthetic hormones market are Pfizer Inc., Johnson & Johnson, AbbVie Inc., Bristol Myers Squibb Company, Sanofi SA, AstraZeneca PLC, Novartis AG, GlaxoSmithKline PLC, Boehringer Ingelheim International GmbH, Novo Nordisk A/S, Merck & Co. Inc, Teva Pharmaceutical Industries Ltd., Ferring B.V., Endo Pharmaceuticals Inc., Lupin Pharmaceuticals Inc., IBSA Institute Biochimique SA, American Regent Inc., McGuff Pharmaceuticals Inc., Anhui Anke Biotechnology Co.Ltd, Acerus Pharmaceuticals Corporation, Slayback Pharma LLC

Access The Complete Synthetic Hormones Market Report:

https://www.thebusinessresearchcompany.com/report/synthetic-hormones-global-market-report

Which Region Commands The Largest Share Of The Synthetic Hormones Market?

North America was the largest region in the synthetic hormones market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the synthetic hormones market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Synthetic Hormones Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=14515&type=smp

Browse Through More Reports Similar to the Global Synthetic Hormones Market 2026, By The Business Research Company

Synthetic Hormones Market Report 2026

https://www.thebusinessresearchcompany.com/report/synthetic-hormones-global-market-report

Bioidentical Hormones Market Report 2026

https://www.thebusinessresearchcompany.com/report/bioidentical-hormones-global-market-report

Hormone Therapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/hormone-therapy-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Size Expansion Is Predicted For The Synthetic Hormones Market Between 2026 And 2030?

The synthetic hormones market has experienced steady expansion in recent years. It is projected to increase from $6.71 billion in 2025 to $7 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 4.4%. The market’s growth during the past period can be ascribed to progress in chemical synthesis, the rising incidence of hormonal disorders, increased knowledge of hormone replacement therapy, the broadening reach of hospital and retail pharmacy networks, and the initial uptake of insulin and growth hormones.

The synthetic hormones market is projected to experience consistent expansion in the coming years. Its value is anticipated to reach $8.34 billion by 2030, growing at a compound annual growth rate (CAGR) of 4.5%. This forecasted growth stems from factors such as the incorporation of AI into hormone therapy, the advancement of oral and non-invasive methods for hormone delivery, the rise of personalized medicine, the broadening reach of online pharmacy platforms, and breakthroughs in peptide and amino acid derivative hormones. Key developments expected during this period include the creation of personalized hormone therapies, sophisticated drug delivery mechanisms, novel synthetic hormone formulations, increased acceptance of hormone replacement therapy, and adherence to regulatory standards and quality benchmarks.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=14515&type=smp

Which Growth Drivers Are Contributing To The Progress Of The Synthetic Hormones Market?

The growing occurrence of hormonal imbalances is projected to drive the expansion of the synthetic hormones market moving forward. Hormonal imbalances arise when the body produces either an excessive or insufficient amount of specific hormones, leading to disturbances caused by aging, stress, lifestyle factors, or underlying medical conditions. These imbalances frequently necessitate therapeutic intervention, and synthetic hormones serve a crucial function by supplementing or replacing deficient hormones to restore normal physiological activity and alleviate associated symptoms. The rising demand for hormone replacement therapy (HRT) reflects the increasing prevalence of these conditions. For instance, in January 2025, according to the World Health Organization, a Switzerland-based intergovernmental organization, polycystic ovary syndrome is a significant public health concern and one of the most common hormonal disorders among women of reproductive age, affecting an estimated 6–13%, with up to 70% of cases remaining undiagnosed. Therefore, the increasing incidence of hormonal imbalances is propelling the growth of the synthetic hormones market.

Which Market Segments Are Examined In The Synthetic Hormones Market Study?

The synthetic hormones market covered in this report is segmented –

1) By Product Type: Steroid Hormones, Peptide Hormone, Amino Acid Derivatives, Other Product Types

2) By Route of Administration: Oral, Nasal, Topical, Intravenous

3) By Application: Growth Hormone Deficiency, Thyroid Hormone Deficiency, Menopause, Male Hypogonadism, Other Applications

4) By End User: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Steroid Hormones: Corticosteroids, Estrogens and Progesterone, Androgens, Progestins

2) By Peptide Hormones: Insulin, Growth Hormones, Thyroid Stimulating Hormones, Leptin

3) By Amino Acid Derivatives: Thyroxine (T4), Epinephrine (Adrenaline), Melatonin

4) By Other Product Types: Vitamin D Derivatives, Prostaglandins, Gonadotropins

Which Trends Are Influencing The Synthetic Hormones Market?

Companies operating in the synthetic hormone market are actively developing innovative biosimilar formulations, such as high-concentration recombinant human growth hormone (rhGH), to meet the increasing demand for more accessible and affordable therapies for growth hormone deficiency and short stature. High-concentration rhGH refers to a synthetic growth hormone, typically somatropin, manufactured using recombinant DNA technology, which features a greater drug load per volume. This allows for smaller injection volumes, enhanced convenience, and potentially improved treatment adherence compared to conventional lower-concentration formulations. For instance, in May 2025, Sandoz AG, a Switzerland-based leader in generics and biosimilars, launched OMNITROPE in a new 15 mg / 1.5 mL concentration specifically for the Egyptian market. This particular formulation contains somatropin produced by recombinant DNA technology in bacteria, is functionally identical to human endogenous growth hormone, and is offered in a more concentrated form to reduce the burden of injections and minimize treatment interruptions. It is indicated for pediatric short stature (e.g., in Turner syndrome, small-for-gestational-age children, Prader–Willi syndrome) and adult GH deficiency, and is priced to expand access under Egypt’s Vision 2030 public-health initiative.

Who Are The Primary Competitors In The Synthetic Hormones Market?

Major companies operating in the synthetic hormones market are Pfizer Inc., Johnson & Johnson, AbbVie Inc., Bristol Myers Squibb Company, Sanofi SA, AstraZeneca PLC, Novartis AG, GlaxoSmithKline PLC, Boehringer Ingelheim International GmbH, Novo Nordisk A/S, Merck & Co. Inc, Teva Pharmaceutical Industries Ltd., Ferring B.V., Endo Pharmaceuticals Inc., Lupin Pharmaceuticals Inc., IBSA Institute Biochimique SA, American Regent Inc., McGuff Pharmaceuticals Inc., Anhui Anke Biotechnology Co.Ltd, Acerus Pharmaceuticals Corporation, Slayback Pharma LLC

Read the full synthetic hormones market report here:

https://www.thebusinessresearchcompany.com/report/synthetic-hormones-global-market-report

What Are The Leading Geographic Regions In The Synthetic Hormones Market?

North America was the largest region in the synthetic hormones market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the synthetic hormones market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Synthetic Hormones Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=14515&type=smp

Browse Through More Reports Similar to the Global Synthetic Hormones Market 2026, By The Business Research Company

Synthetic Hormones Market Report 2026

https://www.thebusinessresearchcompany.com/report/synthetic-hormones-global-market-report

Bioidentical Hormones Market Report 2026

https://www.thebusinessresearchcompany.com/report/bioidentical-hormones-global-market-report

Hormone Therapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/hormone-therapy-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the synthetic hormones market from 2026–2035 with trusted insights from The Business Research Company

By how much is the Synthetic Hormones Market expected to grow between 2026 and 2030?

The synthetic hormones market size has seen steady expansion in recent years. It is anticipated to expand from $6.71 billion in 2025 to $7 billion in 2026, reflecting a compound annual growth rate (CAGR) of 4.4%. This historic growth can be attributed to advancements in chemical synthesis, the increasing prevalence of hormonal disorders, greater awareness of hormone replacement therapy, the expansion of hospital and retail pharmacy networks, and the early adoption of insulin and growth hormones.

The synthetic hormones market size is anticipated to experience consistent expansion in the upcoming years, with a projected increase to $8.34 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 4.5%. This growth during the forecast period is driven by factors such as the integration of AI into hormone therapy, the advancement of oral and non-invasive hormone delivery systems, the expansion of personalized medicine, the proliferation of online pharmacy platforms, and breakthroughs in peptide and amino acid derivative hormones. Significant trends for this period encompass the progression of personalized hormone therapy, sophisticated drug delivery systems, novel synthetic hormone formulations, a rise in the adoption of hormone replacement therapy, and adherence to regulatory compliance and quality standards.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=14515&type=smp

Which Drivers Are Influencing Market Acceleration In The Synthetic Hormones Market?

The increasing occurrence of hormonal imbalances is projected to boost the future expansion of the synthetic hormones market. These imbalances arise when the body’s hormone production is either excessive or insufficient, leading to disruptions attributed to aging, stress, lifestyle elements, or pre-existing medical conditions. Such imbalances frequently necessitate medical treatment, where synthetic hormones are crucial for supplementing or substituting lacking hormones, thereby restoring normal bodily functions and easing related symptoms. The rising need for hormone replacement therapy (HRT) indicates the expanding prevalence of these conditions. For example, as reported by the World Health Organization, a Switzerland-based intergovernmental organization, in January 2025, polycystic ovary syndrome represents a major public health issue and ranks among the most frequent hormonal disorders in women of reproductive age, impacting an estimated 6–13%, with potentially up to 70% of cases still undiagnosed. Consequently, the growing occurrence of hormonal imbalances is fueling the expansion of the synthetic hormones market.

What Segments Are Identified Within The Structure Of The Synthetic Hormones Market?

The synthetic hormones market covered in this report is segmented –

1) By Product Type: Steroid Hormones, Peptide Hormone, Amino Acid Derivatives, Other Product Types

2) By Route of Administration: Oral, Nasal, Topical, Intravenous

3) By Application: Growth Hormone Deficiency, Thyroid Hormone Deficiency, Menopause, Male Hypogonadism, Other Applications

4) By End User: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Steroid Hormones: Corticosteroids, Estrogens and Progesterone, Androgens, Progestins

2) By Peptide Hormones: Insulin, Growth Hormones, Thyroid Stimulating Hormones, Leptin

3) By Amino Acid Derivatives: Thyroxine (T4), Epinephrine (Adrenaline), Melatonin

4) By Other Product Types: Vitamin D Derivatives, Prostaglandins, Gonadotropins

How Are Emerging Trends Affecting The Progression Of The Synthetic Hormones Market?

Leading firms within the synthetic hormone market are concentrating on creating novel biosimilar formulations, including high-concentration recombinant human growth hormone (rhGH), to address the increasing need for more readily available and cost-effective treatments for growth hormone deficiency and short stature. This high-concentration rhGH is defined as a type of synthetic growth hormone (often somatropin) made using recombinant DNA technology, featuring a higher drug load per volume. This characteristic enables reduced injection volumes, enhanced user convenience, and potentially improved adherence to treatment when contrasted with conventional lower-concentration options. An example of this is seen in May 2025, when Sandoz AG, a Switzerland-based leader in generics and biosimilars, introduced OMNITROPE with a new 15 mg / 1.5 mL concentration specifically for the Egyptian market. This particular formulation incorporates somatropin, which is manufactured through recombinant DNA technology in bacteria, functions identically to human endogenous growth hormone, and is presented in a more concentrated form to alleviate the burden of injections and lessen treatment interruptions. Its indications include pediatric short stature (for example, in cases of Turner syndrome, small-for-gestational-age children, and Prader–Willi syndrome) and adult GH deficiency. Furthermore, its pricing strategy aims to expand access as part of Egypt’s Vision 2030 public-health initiative.

Which Key Players Are Driving Competition In The Synthetic Hormones Market?

Major companies operating in the synthetic hormones market are Pfizer Inc., Johnson & Johnson, AbbVie Inc., Bristol Myers Squibb Company, Sanofi SA, AstraZeneca PLC, Novartis AG, GlaxoSmithKline PLC, Boehringer Ingelheim International GmbH, Novo Nordisk A/S, Merck & Co. Inc, Teva Pharmaceutical Industries Ltd., Ferring B.V., Endo Pharmaceuticals Inc., Lupin Pharmaceuticals Inc., IBSA Institute Biochimique SA, American Regent Inc., McGuff Pharmaceuticals Inc., Anhui Anke Biotechnology Co.Ltd, Acerus Pharmaceuticals Corporation, Slayback Pharma LLC

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/synthetic-hormones-global-market-report

Which Region Is Projected To Lead The Synthetic Hormones Market During The Forecast Period?

North America was the largest region in the synthetic hormones market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the synthetic hormones market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Synthetic Hormones Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=14515&type=smp

Browse Through More Reports Similar to the Global Synthetic Hormones Market 2026, By The Business Research Company

Synthetic Hormones Market Report 2026

https://www.thebusinessresearchcompany.com/report/synthetic-hormones-global-market-report

Bioidentical Hormones Market Report 2026

https://www.thebusinessresearchcompany.com/report/bioidentical-hormones-global-market-report

Hormone Therapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/hormone-therapy-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the synthetic hormones market from 2025–2034 with trusted insights from The Business Research Company

What Is The Current Size And Expected Growth Outlook For The Synthetic Hormones Market?

The market size for synthetic hormones has shown robust growth in recent years. It is forecast to expand from $6.38 billion in 2024 to $6.71 billion in 2025, driven by a compound annual growth rate (CAGR) of 5.1%. This past growth can be attributed to factors such as animal growth promotion, performance enhancement, environmental impact, fertility treatments, and menopausal symptom management.

The market for synthetic hormones is anticipated to experience consistent expansion over the upcoming years. This market is projected to reach “$7.98 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 4.4%. This anticipated growth during the forecast period is attributable to several factors, including the expanding transgender healthcare market, increasing healthcare spending and insurance penetration, new regulatory approvals, and the broadening applications of synthetic hormones. Key trends expected within this period encompass the emergence of plant-based hormone therapy, the incorporation of hormone therapy into anti-aging regimens, innovations in drug delivery technology, and an emphasis on hormone-free birth control methods.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=14515&type=smp

Which Growth Drivers Are Propelling The Synthetic Hormones Market?

The growing occurrence of hormonal imbalances is anticipated to stimulate the expansion of the synthetic hormones market moving forward. A hormonal imbalance refers to an excessive or insufficient amount of a hormone in the blood, which may result from stress, aging, various medical conditions, or lifestyle choices, disrupting the body’s natural hormone production and regulatory processes. Synthetic hormones are utilized to augment or replace natural hormones in cases of imbalance, thereby aiding in the regulation of bodily functions and mitigating symptoms associated with either deficiencies or excesses. For instance, according to the NHS Business Services Authority, a UK-based non-departmental public body, around 7.80 million hormone replacement therapy (HRT) items were prescribed in England in 2022, marking a 35.0% increase from the previous year. Therefore, the escalating incidence of hormonal imbalances is a key driver for the growth of the synthetic hormones market.

Which Segmentation Factors Are Most Significant In The Synthetic Hormones Market Analysis?

The synthetic hormones market covered in this report is segmented –

1) By Product Type: Steroid Hormones, Peptide Hormone, Amino Acid Derivatives, Other Product Types

2) By Route of Administration: Oral, Nasal, Topical, Intravenous

3) By Application: Growth Hormone Deficiency, Thyroid Hormone Deficiency, Menopause, Male Hypogonadism, Other Applications

4) By End User: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Steroid Hormones: Corticosteroids, Estrogens and Progesterone, Androgens, Progestins

2) By Peptide Hormones: Insulin, Growth Hormones, Thyroid Stimulating Hormones, Leptin

3) By Amino Acid Derivatives: Thyroxine (T4), Epinephrine (Adrenaline), Melatonin, Serotonin

4) By Other Product Types: Vitamin D Derivatives, Prostaglandins, Gonadotropins

What New Opportunities Are Emerging From Trends In The Synthetic Hormones Market?

Leading firms within the synthetic hormone market are concentrating on creating advanced products, such as recombinant human growth hormone, with the goal of boosting their market profitability. This synthetic hormone, recombinant human growth hormone, serves as a treatment for growth hormone deficiency in both pediatric and adult patients, alongside specific medical conditions linked to such deficiency. For example, in February 2022, Pfizer Inc., a US pharmaceutical firm, and OPKO Health Inc., a US medical test and medication enterprise, obtained marketing approval for their once-weekly NGENLA (somatrogon) injections across the European Union. The purpose of these injections is to address pediatric growth hormone deficiency in children and adolescents aged at least three years old. This novel long-acting injection offers an alternative therapy for individuals experiencing growth disturbances resulting from inadequate growth hormone secretion. NGENLA is given subcutaneously and remains effective in the body for a longer duration compared to daily growth hormone injections, enabling its administration once a week.

Who Are The Most Influential Companies In The Synthetic Hormones Market?

Major companies operating in the synthetic hormones market are Pfizer Inc., Johnson & Johnson, AbbVie Inc., Bristol Myers Squibb Company, Sanofi SA, AstraZeneca PLC, Novartis AG, GlaxoSmithKline PLC, Gilead Sciences Inc., Boehringer Ingelheim International GmbH, Novo Nordisk A/S, Merck & Co. Inc., Teva Pharmaceutical Industries Ltd., Ferring B.V., Endo Pharmaceuticals Inc., Lupin Pharmaceuticals Inc., IBSA Institute Biochimique SA, American Regent Inc., McGuff Pharmaceuticals Inc., Anhui Anke Biotechnology Co.Ltd., Lyndra Therapeutics Inc., Acerus Pharmaceuticals Corporation, Arch BioPartners Inc., Slayback Pharma LLC

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/synthetic-hormones-global-market-report

Which Region Holds The Largest Share In The Synthetic Hormones Market Today?

North America was the largest region in the synthetic hormones market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the synthetic hormones market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=14515&type=smp

Browse Through More Reports Similar to the Global Synthetic Hormones Market 2025, By The Business Research Company

Synthetic Fibers Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/synthetic-fibers-global-market-report

Synthetic Rubber And Fibers Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/synthetic-rubber-and-fibers-global-market-report

Synthetic Sweeteners Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/synthetic-sweeteners-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim 20% Off Global Market Reports With Code ONLINE20 – Insights on Tariff Effects, Global Trade, and Industry Disruptors

What CAGR And Valuation Are Anticipated For The Synthetic Hormones Market?

In the last few years, the synthetic hormones market has seen substantial growth. The market size is projected to increase from $6.38 billion in 2024 to $6.71 billion in 2025, showing a compound annual growth rate (CAGR) of 5.1%. The past growth can be linked to factors such as animal growth enhancement, performance improvement, environmental impact, fertility therapies, and management of menopausal symptoms.

The market for synthetic hormones is projected to experience a consistent expansion in the upcoming years, reaching “$7.98 billion in 2029”, with a Compound Annual Growth Rate (CAGR) of 4.4%. This projected growth within the forecast period is largely due to the increasing expansion of the transgender healthcare market, escalating healthcare expenses and insurance coverage, established regulatory approvals, and the widening application scope of synthetic hormones. Noteworthy trends expected over the forecast period incorporate the popularity of plant-based hormone therapy, the incorporation of hormone therapy in anti-aging regimens, advancements in technology for drug delivery, as well as an increased focus on hormone-free methods of birth control.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=14515&type=smp

Which Growth Drivers Are Shaping The Synthetic Hormones Market Outlook?

Rising cases of hormonal imbalances are anticipated to fuel the expansion of the synthetic hormones market in the future. Hormonal imbalance, characterized by having excessive or insufficient levels of a hormone in the bloodstream, can stem from stress, aging, medical issues, or lifestyle habits, interfering with the body’s normal production and control of hormones. Synthetic hormones serve to supplement or substitute natural hormones when hormonal imbalances occur, helping to govern physical functions and mitigate symptoms linked to deficiencies or surpluses. For example, data from the NHS Business Services Authority, a non-departmental public body in the UK, indicates that around 7.80 million hormone replacement therapy (HRT) items were prescribed in England in 2022, signifying a 35.0% rise from the previous year. Hence, the escalating prevalence of hormonal imbalances is propelling the expansion of the synthetic hormones market.

How Is The Synthetic Hormones Market Organized By Different Segments?

The synthetic hormones market covered in this report is segmented –

1) By Product Type: Steroid Hormones, Peptide Hormone, Amino Acid Derivatives, Other Product Types

2) By Route of Administration: Oral, Nasal, Topical, Intravenous

3) By Application: Growth Hormone Deficiency, Thyroid Hormone Deficiency, Menopause, Male Hypogonadism, Other Applications

4) By End User: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Steroid Hormones: Corticosteroids, Estrogens and Progesterone, Androgens, Progestins

2) By Peptide Hormones: Insulin, Growth Hormones, Thyroid Stimulating Hormones, Leptin

3) By Amino Acid Derivatives: Thyroxine (T4), Epinephrine (Adrenaline), Melatonin, Serotonin

4) By Other Product Types: Vitamin D Derivatives, Prostaglandins, Gonadotropins

What Current And Upcoming Trends Are Shaping The Synthetic Hormones Market?

Leading businesses in the synthetic hormone market are prioritizing the development of novel products, such as the recombinant human growth hormone, to boost their market profitability. The recombinant human growth hormone is a man-made hormone used in the treatment of growth hormone deficiencies in both children and adults, as well as some medical conditions associated with this deficiency. For example, Pfizer Inc., an American pharmaceutical company, and OPKO Health Inc., an American medical testing and medication enterprise, got approval in February 2022 to market once-weekly NGENLA (somatrogon) injections in the European Union. These injections are designed to address pediatric growth hormone deficiency in children and adolescents aged three years and above. This new long-lasting injection offers an option for individuals suffering from growth disorders due to inadequate growth hormone production. NGENLA is delivered through subcutaneous injection and remains in the system longer than daily growth hormone injections, thus requiring only once-a-week administration.

Who Are The Most Influential Companies In The Synthetic Hormones Market?

Major companies operating in the synthetic hormones market are Pfizer Inc., Johnson & Johnson, AbbVie Inc., Bristol Myers Squibb Company, Sanofi SA, AstraZeneca PLC, Novartis AG, GlaxoSmithKline PLC, Gilead Sciences Inc., Boehringer Ingelheim International GmbH, Novo Nordisk A/S, Merck & Co. Inc., Teva Pharmaceutical Industries Ltd., Ferring B.V., Endo Pharmaceuticals Inc., Lupin Pharmaceuticals Inc., IBSA Institute Biochimique SA, American Regent Inc., McGuff Pharmaceuticals Inc., Anhui Anke Biotechnology Co.Ltd., Lyndra Therapeutics Inc., Acerus Pharmaceuticals Corporation, Arch BioPartners Inc., Slayback Pharma LLC

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/synthetic-hormones-global-market-report

Which Region Dominates The Synthetic Hormones Market Today?

North America was the largest region in the synthetic hormones market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the synthetic hormones market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=14515&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Current and Projected Market Size of the Synthetic Hormones Industry?

There has been significant growth in the synthetic hormones market over the past few years. This market is projected to expand from $6.38 billion in 2024 to $6.71 billion in 2025, experiencing a compound annual growth rate (CAGR) of 5.1%. The growth during the historical period can be traced back to factors such as animal growth stimulation, performance improvement, environmental influence, fertility treatments, and management of menopause symptoms.

Over the upcoming years, the market size for synthetic hormones is projected to experience a stable growth, reaching a worth of “$7.98 billion in 2029” with a compound annual growth rate (CAGR) of 4.4%. The growth expected within this forecasting period can be credited to the broadening of transgender healthcare services, rising expenditure and coverage in healthcare, authorized approvals, and the widening use of synthetic hormones. Predicted trends within this period denote the ascent of plant-derived hormone treatment, incorporation of hormone therapy in anti-aging care, advancements in drug delivery technology, and an emphasis on birth control without the use of hormones.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=14515&type=smp

#Which Factors Are Currently Driving The Growth Of The Synthetic Hormones Market?

The surge in the occurrence of hormonal imbalances is anticipated to drive the expansion of the synthetic hormones market. Hormonal imbalance is characterized by a high or low level of a certain hormone in the bloodstream, an anomaly that can result from stress, age, certain diseases, or lifestyle choices, disrupting the normal generation and control of body hormones. Synthetic hormones are deployed to augment or replace natural hormones during hormonal imbalances, enabling regulation of bodily functions and the reduction of symptoms associated with hormonal deficiencies or oversupply. To illustrate, the NHS Business Services Authority, a non-departmental public body based in the UK, stated that around 7.80 million Hormone Replacement Therapy (HRT) items were prescribed in England in 2022, representing a 35.0% rise from the last year. Consequently, the surge in the occurrence of hormonal imbalances is fostering the expansion of the synthetic hormones market.

The synthetic hormones market covered in this report is segmented –

1) By Product Type: Steroid Hormones, Peptide Hormone, Amino Acid Derivatives, Other Product Types

2) By Route of Administration: Oral, Nasal, Topical, Intravenous

3) By Application: Growth Hormone Deficiency, Thyroid Hormone Deficiency, Menopause, Male Hypogonadism, Other Applications

4) By End User: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Steroid Hormones: Corticosteroids, Estrogens and Progesterone, Androgens, Progestins

2) By Peptide Hormones: Insulin, Growth Hormones, Thyroid Stimulating Hormones, Leptin

3) By Amino Acid Derivatives: Thyroxine (T4), Epinephrine (Adrenaline), Melatonin, Serotonin

4) By Other Product Types: Vitamin D Derivatives, Prostaglandins, Gonadotropins

Which Emerging Trends And Strategic Shifts Are Shaping The Synthetic Hormones Market?

Prominent players in the synthetic hormone industry are concentrating on product innovation, such as the recombinant human growth hormone, to improve their market profitability. The recombinant human growth hormone is an artificial hormone used for the treatment of growth hormone deficiencies in both children and adults, including other medical conditions related to growth hormone absence. For instance, in February 2022, Pfizer Inc., a US pharmaceutical firm, along with OPKO Health Inc., a US medical test and medication corporation, obtained marketing approval for their NGENLA (somatrogon) once-weekly injections in the European Union, aimed at treating pediatric growth hormone deficiency in children and adolescents aged at least three years old. This novel long-acting injection offers an alternative for individuals with growth disorders due to inadequate growth hormone secretion. Unlike daily growth hormone injections, NGENLA is injected subcutaneously and endures in the body longer, enabling its weekly administration.

Who Are The Main Participants Shaping The Synthetic Hormones Market Landscape?

Major companies operating in the synthetic hormones market are Pfizer Inc., Johnson & Johnson, AbbVie Inc., Bristol Myers Squibb Company, Sanofi SA, AstraZeneca PLC, Novartis AG, GlaxoSmithKline PLC, Gilead Sciences Inc., Boehringer Ingelheim International GmbH, Novo Nordisk A/S, Merck & Co. Inc., Teva Pharmaceutical Industries Ltd., Ferring B.V., Endo Pharmaceuticals Inc., Lupin Pharmaceuticals Inc., IBSA Institute Biochimique SA, American Regent Inc., McGuff Pharmaceuticals Inc., Anhui Anke Biotechnology Co.Ltd., Lyndra Therapeutics Inc., Acerus Pharmaceuticals Corporation, Arch BioPartners Inc., Slayback Pharma LLC

https://www.thebusinessresearchcompany.com/report/synthetic-hormones-global-market-report

Which Region Currently Holds The Largest Share In The Synthetic Hormones Market?

North America was the largest region in the synthetic hormones market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the synthetic hormones market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=14515&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has The Synthetic Hormones Market Growth Evolved From 2024 To 2025, And What’s Ahead?

In recent years, the synthetic hormones market has seen significant growth. An increase from $6.38 billion in 2024 to $6.71 billion in 2025 is expected, with a compound annual growth rate (CAGR) of 5.1%. Factors such as animal growth stimulation, performance improvement, environmental effects, fertility therapies, and menopausal symptom control account for the expansion during the historic period.

The market size of synthetic hormones is expected to exhibit a steady rise in the upcoming years, reaching $7.98 billion in 2029 with a 4.4% compound annual growth rate. The growth observed during the forecast period can be a result of the growing transgender healthcare market, an increase in health expenditure and insurance coverage, regulatory authorizations, and widening usage of synthetic hormones. Several trends are expected to be prominent during the forecast period including the increase of plant-based hormone therapy, the incorporation of hormone therapy into anti-ageing treatments, technological developments in drug delivery, and heightened interest in hormone-free birth control.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=14515&type=smp

What are the Fundamental Drivers and Innovations Shaping the Synthetic Hormones Market?

The escalating prevalence of hormonal discrepancies is expected to drive the expansion of the synthetic hormones market. Hormonal imbalance entails having an abundant or deficient amount of a specific hormone in the bloodstream arising from stress, aging, medical disorders, or lifestyle decisions, interrupting the typical production and management of hormones in the system. Synthetic hormones are utilized to boost or substitute natural hormones for these imbalances, aiding in the regulation of bodily functions and the mitigation of symptoms due to deficiencies or surpluses. For example, the NHS Business Services Authority, a non-departmental public entity in the UK, reported that in 2022, about 7.80 million hormone replacement therapy (HRT) items were prescribed in England, marking an escalation of 35.0% from the year before. Hence, the growing prevalence of hormonal discrepancies is spurring the expansion of the synthetic hormones market.

How Is the Synthetic Hormones Market Segmented?

The synthetic hormones market covered in this report is segmented –

1) By Product Type: Steroid Hormones, Peptide Hormone, Amino Acid Derivatives, Other Product Types

2) By Route of Administration: Oral, Nasal, Topical, Intravenous

3) By Application: Growth Hormone Deficiency, Thyroid Hormone Deficiency, Menopause, Male Hypogonadism, Other Applications

4) By End User: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Steroid Hormones: Corticosteroids, Estrogens and Progesterone, Androgens, Progestins

2) By Peptide Hormones: Insulin, Growth Hormones, Thyroid Stimulating Hormones, Leptin

3) By Amino Acid Derivatives: Thyroxine (T4), Epinephrine (Adrenaline), Melatonin, Serotonin

4) By Other Product Types: Vitamin D Derivatives, Prostaglandins, Gonadotropins

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=14515&type=smp

Which Regions Are Driving the Next Phase of the Synthetic Hormones Market Growth?

North America was the largest region in the synthetic hormones market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the synthetic hormones market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Key Trends Are Shaping the Future of the Synthetic Hormones Market?

Leaders in the synthetic hormone market, like Pfizer Inc. and OPKO Health Inc., are investing in the creation of pioneering items, for instance, the recombinant human growth hormone, in an attempt to raise their earnings. This artificial hormone caters to both children and adults suffering from growth hormone deficiency and connected health issues. In February 2022, the duo gained marketing clearance in the European Union for their latest venture, once-weekly NGENLA (somatrogon) injections. Aimed at treating growth hormone deficiency in children and adolescents older than three years, these injections offer an alternative for those afflicted with growth issues due to inadequate growth hormone secretion. NGENLA, which is given subcutaneously, lingers longer in the body in comparison to daily growth hormone injections, thus requiring only a weekly dose.

View the full report here:

https://www.thebusinessresearchcompany.com/report/synthetic-hormones-global-market-report

How Is the Synthetic Hormones Market Defined and What Are Its Core Parameters?

Synthetic hormones are artificially produced substances that mimic the function of natural hormones in the body. These hormones are typically created through chemical synthesis rather than being derived from natural sources and are used in medical treatments to regulate various physiological processes or to replace hormones that the body may not produce in sufficient quantities.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=14515

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Growth Rate of the Synthetic Hormones Market?

The market size of synthetic hormones has seen robust growth in the past few years. The market is projected to expand from $6.38 billion in 2024 to $6.77 billion in 2025, experiencing a compound annual growth rate (CAGR) of 6.2%. This growth during the historic period can be traced back to factors such as animal growth promotion, performance enhancement, impact of environment, fertility treatments, and management of menopausal symptoms.

What Growth Rate Is Forecasted for the Synthetic Hormones Market by 2029?

Over the coming years, the market size for synthetic hormones is projected to witness consistent growth. By 2029, it is estimated to reach $8.15 billion, with a compound annual growth rate (CAGR) of 4.7%. The anticipated growth during this period can be ascribed to the augmentation of the transgender healthcare sphere, increased healthcare spending and insurance coverage, regulatory approvals, and broadened usage of synthetic hormones. Key trends to look out for during this forecast period include the emergence of plant-based hormone therapy, the incorporation of hormone therapy into anti-aging treatments, advances in drug delivery technology, and a focus on hormone-free birth control.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=14515&type=smp

Which Key Companies Are Shaping the Future of the Synthetic Hormones Market?

Major companies operating in the synthetic hormones market are Pfizer Inc., Johnson & Johnson, AbbVie Inc., Bristol Myers Squibb Company, Sanofi SA, AstraZeneca PLC, Novartis AG, GlaxoSmithKline PLC, Gilead Sciences Inc., Boehringer Ingelheim International GmbH, Novo Nordisk A/S, Merck & Co. Inc., Teva Pharmaceutical Industries Ltd., Ferring B.V., Endo Pharmaceuticals Inc., Lupin Pharmaceuticals Inc., IBSA Institute Biochimique SA, American Regent Inc., McGuff Pharmaceuticals Inc., Anhui Anke Biotechnology Co.Ltd., Lyndra Therapeutics Inc., Acerus Pharmaceuticals Corporation, Arch BioPartners Inc., Slayback Pharma LLC

Which Factors Are Driving Demand in the Synthetic Hormones Industry?

The synthetic hormones market’s growth is anticipated to be fueled by the rising prevalence of hormonal imbalances. Hormonal imbalances refer to the condition where there is either an excess or a deficiency of a hormone in the bloodstream. This can often happen due to stress, aging, certain medical conditions, or lifestyle decisions, which disrupt the typical production and regulation of hormones within the body. Synthetic hormones serve as a supplement or substitution for natural hormones during such imbalances, as they help to manage bodily functions and mitigate the symptoms linked with hormonal deficiencies or surpluses. For example, in 2022, the NHS Business Services Authority, a non-departmental public body in the UK, reported a prescription of approximately 7.80 million Hormone Replacement Therapy (HRT) items in England. This was a surge of about 35.0% compared with the previous year. As a result, the rising occurrence of hormonal imbalances is propelling the expansion of the synthetic hormones market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=14515&type=smp

How Is the Synthetic Hormones Market Segmented by Several Divisions?

The synthetic hormones market covered in this report is segmented –

1) By Product Type: Steroid Hormones, Peptide Hormone, Amino Acid Derivatives, Other Product Types

2) By Route of Administration: Oral, Nasal, Topical, Intravenous

3) By Application: Growth Hormone Deficiency, Thyroid Hormone Deficiency, Menopause, Male Hypogonadism, Other Applications

4) By End User: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Steroid Hormones: Corticosteroids, Estrogens and Progesterone, Androgens, Progestins

2) By Peptide Hormones: Insulin, Growth Hormones, Thyroid Stimulating Hormones, Leptin

3) By Amino Acid Derivatives: Thyroxine (T4), Epinephrine (Adrenaline), Melatonin, Serotonin

4) By Other Product Types: Vitamin D Derivatives, Prostaglandins, Gonadotropins

What are the Emerging Market Trends Driving the Growth of the Synthetic Hormones Industry?

Key businesses in the synthetic hormone industry are situating themselves to increase their market shares by introducing novel products, for instance, the recombinant human growth hormone. This manufactured hormone is utilized for managing growth hormone deficiency in both children and adults and treating specific health issues linked with this deficiency. As an illustrative example, Pfizer Inc., an American pharmaceutical company, and OPKO Health Inc., also an American company specializing in medical testing and medication, gained marketing clearance in the European Union for NGENLA (somatrogon) injections administered once per week, as of February 2022. The approval is specifically for dealing with pediatric growth hormone deficiency in children and teens aged three years and above. It provides a viable option for those affected by growth irregularities that result from inadequate growth hormone production. As compared to the daily growth hormone injections, NGENLA, which is injected subcutaneously, remains effective within the body for a longer period; hence, it only requires weekly administration.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/synthetic-hormones-global-market-report

Which Regions Are Driving Growth in the Synthetic Hormones Market?

North America was the largest region in the synthetic hormones market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the synthetic hormones market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=14515

This Report Delivers Insight On:

1. How big is the synthetic hormones market, and how is it changing globally?

2. Who are the major companies in the synthetic hormones market, and how are they performing?

3. What are the key opportunities and risks in the synthetic hormones market right now?

4. Which products or customer segments are growing the most in the synthetic hormones market?

5. What factors are helping or slowing down the growth of the synthetic hormones market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model